查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1789864

注射器市场规模、份额和趋势分析报告：按用途、设计、应用、材料、最终用途、地区和细分市场预测，2025 年至 2033 年

Syringes Market Size, Share & Trends Analysis Report By Usage, By Design, By Application, By Material, By End Use, By Region And Segment Forecasts, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

注射器市场摘要

预计 2024 年全球注射器市场规模为 170.3 亿美元，到 2033 年将达到 356.1 亿美元，2025 年至 2033 年的复合年增长率为 8.66%。注射器的需求受到慢性疾病负担加重、外科手术数量增加以及住院人数增加的推动。

此外，注射器技术的进步预计将推动市场成长。慢性病的流行及其导致的住院人数上升是主要的市场驱动力。根据世界卫生组织2024年12月发布的数据，2021年慢性病在全球夺走了至少4,300万人的生命。此外，梅奥诊所2024年2月发布的一项研究预测，到2030年，慢性病对全球带来的经济负担预计将达到47兆美元。这一日益加重的负担凸显了对医疗用品（包括注射器）日益增长的需求，因为医疗保健系统正努力管理和治疗这些长期疾病。

此外，住院患者和手术数量的增加将在未来几年推动注射器的需求。随着整形手术、心血管手术和整形外科手术等外科手术在各国和地区的普及，对注射器的需求也不断增长。这些手术通常需要使用注射器进行麻醉和给药，这导致整体需求激增。此外，手术技术的进步和患者数量的增加也推动了医疗保健机构对注射器的需求不断增长。

预计未来几年，对安全性的日益重视以及自动拆卸注射器的普及将推动市场成长。各公司正不断利用这些先进的解决方案来创新其产品。例如，2024年3月，Hindusta注射器和医疗器材公司推出了Dispojekt，这是一款配备安全针的一次性注射器。这些注射器旨在降低医护人员意外针刺伤（NSI）的风险，降低感染控製成本，最大限度地减少与处置和培训相关的费用，并最终为医疗保健行业带来长期经济效益。

此外，疫苗接种和免疫接种需求的不断增长也推动了注射器的需求，新参与企业正专注于生产自动防针刺注射器以满足此需求。例如，根据VaccinesWork 2024年2月发布的数据，Revital Healthcare成为非洲第一个生产经世卫组织预先认证的一次性安全注射器的製造商。这些非洲製造的自动停用（AD）注射器正在加强整个非洲大陆的疫苗接种工作。在肯亚，免疫系统强烈建议使用AD注射器。 AD注射器的设计使其在单次注射后自动锁定，防止重复使用，使其成为疫苗接种安全的黄金标准。

Revital Healthcare (EPZ) Limited 董事 Ronique R. Vora 表示：“预计整个肯亚大陆的注射器平均运输时间将减少 80% 至 90%。”

「儘管印度是最大的注射器製造商，但我们还是突破了壁垒，将这些注射器出口到 35 多个国家，包括印度、四个欧洲国家和其他非洲国家，」沃拉说道，他也是肯亚卫生署疟疾消除委员会和基金的创始成员之一。

预计此类疫苗注射器的製造和出口成长将在未来几年推动市场成长。

请索取此报告的免费样本以供参考。

此外，各种尺寸注射器的供应也支撑了市场的成长。下图重点介绍了2022年和2023年几种自动停用注射器的价格、尺寸和品牌名称。

目录

第一章调查方法与范围

第二章执行摘要

第三章註射器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 注射器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章註射器市场：按用途的估计和趋势分析

  • 细分仪表板
  • 全球注射器市场按用途变化分析
  • 全球注射器市场规模及趋势分析（依用途，2021-2033）
  • 一次性注射器
  • 可重复使用的注射器

第五章註射器市场：设计估算与趋势分析

  • 细分仪表板
  • 全球注射器市场设计差异分析
  • 全球注射器市场规模与趋势分析（依设计，2021-2033 年）
  • 传统注射器
  • 安全注射器
  • 预填充式注射器（PFS）
  • 智慧注射器

第六章註射器市场：按应用的估计和趋势分析

  • 细分仪表板
  • 全球注射器市场趋势分析（按应用）
  • 全球注射器市场规模及趋势分析（按应用，2021-2033）
  • 疫苗和免疫接种
  • 过敏反应
  • 类风湿性关节炎
  • 糖尿病
  • 自体免疫疾病
  • 肿瘤学
  • 其他的

第七章註射器市场：依材料估算与趋势分析

  • 细分仪表板
  • 全球注射器市场材料波动分析
  • 全球注射器市场规模及趋势分析（按材料，2021-2033）
  • 塑胶注射器
  • 玻璃注射器

第 8 章：注射器市场：依最终用途的估算与趋势分析

  • 细分仪表板
  • 全球注射器市场按最终用途变化分析
  • 全球注射器市场规模与趋势分析（依最终用途，2021-2033 年）
  • 直接竞标
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章註射器市场：区域估计和趋势分析（按设计、用途、应用、材料和最终用途）

  • 区域仪表板
  • 2021-2033 年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Global Key company market share analysis, 2024
    • Revital
    • Hindustan Syringes &Medical Devices Ltd
    • Wuxi Yushou Medical Appliances Co., Ltd
    • Nipro Europe Group Companies
    • Abu Dhabi Medical Devices Company
    • B. Braun SE
    • BD
    • Sharps Technology, Inc.
    • Cardinal Health
    • Vita Needle Company
    • Terumo Europe NV
    • Taisei Kako Ltd
    • ulti med Products
    • Henke Sass Wolf GmbH
    • ITO CORPORATION
    • Retractable Technologies, Inc.
    • kohope.com
    • Al Shifa Medical Products Co
    • Liaoning Kangyi Medical Equipment Co., Ltd
    • CANE SPA
    • SMB Corporation of India
    • Lifelong Meditech Private Limited.
    • OSAKA CHEMICAL Co., Ltd
    • JMS Co.Ltd
    • APEX MEDICAL DEVICES
    • Cartel Health Care Pvt. Ltd
    • VEM Tooling Co., Ltd.（VEM Thailand Co., Ltd.）
    • Fresenius Kabi Canada Ltd
    • ICU Medical, Inc.
  • 热图分析/企业市场分析
  • 2024年企业市场占有率预测分析
  • 其他主要市场公司名单
Product Code: GVR-4-68038-077-4

Syringes Market Summary

The global syringes market size was estimated at USD 17.03 billion in 2024 and is projected to reach USD 35.61 billion by 2033, growing at a CAGR of 8.66% from 2025 to 2033. The demand for syringes is rising owing to the increasing burden of chronic disorders, the rising number of surgical procedures, and the growing hospitalizations.

In addition, the advancements in syringes are anticipated to propel the market growth. The increasing prevalence of chronic diseases and the resulting hospitalizations are major market drivers. According to the data published by the WHO in December 2024, chronic diseases claimed the lives of at least 43 million people globally in 2021. In addition, a study published by the Mayo Clinic in February 2024 projects that the global economic burden of chronic diseases will reach an estimated USD 47 trillion by 2030. This growing burden underscores the rising demand for medical supplies, including syringes, as healthcare systems work to manage and treat these long-term conditions.

Furthermore, the rising number of hospitalizations and an increasing volume of surgical procedures drive the demand for syringes in the coming years. As surgical interventions, including cosmetic, cardiac, and orthopedic surgeries, become more prevalent across various countries and regions, the need for syringes grows. These surgeries often require the use of syringes for anesthesia and medication delivery, contributing to the overall surge in demand. Moreover, advancements in surgical techniques and a growing patient population further support this rising need for syringes in healthcare settings.

The growing emphasis on safety and auto-disable syringes is expected to propel market growth in the coming years. Companies are increasingly innovating their product offerings with these advanced solutions. For example, in March 2024, Hindusta Syringes and Medical Devices introduced the Dispojekt single-use syringes with safety needles. These syringes aim to reduce the risk of accidental needle-stick injuries (NSIs) among healthcare workers, lower infection control costs, and minimize expenses related to disposal and training, ultimately delivering long-term financial benefits to the healthcare sector.

Moreover, the growing demand for vaccinations and immunizations is driving the need for syringes, with new market entrants focusing on manufacturing auto-disable syringes to meet this demand. For example, according to data published by VaccinesWork in February 2024, Revital Healthcare has become the first African manufacturer of WHO-prequalified, single-use, safe syringes. These African-made auto-disable (AD) syringes enhance immunization efforts across the continent. In Kenya, the immunization system strongly advocates for AD syringes, which are developed to prevent reuse by locking automatically post single injection, making them the gold standard for vaccination safety.

"Average syringe transport times are expected to decrease by up to 80-90% on the continent". Said Roneek R. Vora, director, Revital Healthcare (EPZ) Limited

"We broke barriers by exporting these syringes to more than 35 countries, including India - despite India being a syringe production powerhouse -and four European countries, and to other African countries." Says Vora, who is also a founding member of the Kenyan Ministry of Health's End Malaria Council & Fund.

Such increasing manufacturing and export of auto-disabled syringes for vaccinations and immunizations is anticipated to propel market growth in the coming years.

To learn more about this report, request a free sample copy

In addition, the availability of syringes in various sizes supports market growth. The pictorial representation below highlights the prices of some auto-disabled syringes along with their size and brand name for 2022 and 2023.

Global Syringes Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global syringes market report based on design, usage, application, material, end use, and region:

  • Usage Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposable Syringes
  • Reusable Syringes
  • Design Outlook (Revenue, USD Million, 2021 - 2033)
  • Conventional Syringes
  • Safety Syringes
    • Retractable Safety Syringes
    • Non-Retractable Safety Syringes
  • Prefilled Syringes (PFS)
  • Smart Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccines and Immunizations
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Autoimmune Diseases
  • Oncology
  • Others
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Plastic Syringes
  • Glass Syringes
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct Tenders
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Design
    • 1.1.2. Usage
    • 1.1.3. Application
    • 1.1.4. Material
    • 1.1.5. End-use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for vaccination and immunization
      • 3.2.1.2. Rising adoption of safety and prefilled syringes
      • 3.2.1.3. Increasing disease burden
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Rising production capacities for syringes
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Recalls of syringes
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Increasing development of auto-disable syringes
      • 3.2.3.3. Growth potential in emerging economies in syringes market
      • 3.2.3.4. Rising distribution partnerships
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Potential complications and risks associated with syringes
  • 3.3. Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Syringes Market: Usage Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Syringes Market Usage Movement Analysis
  • 4.3. Global Syringes Market Size & Trend Analysis, by Usage, 2021 to 2033 (USD Million)
  • 4.4. Disposable Syringes
    • 4.4.1. Disposable syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reusable Syringes
    • 4.5.1. Reusable syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Syringes Market: Design Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Syringes Market Design Movement Analysis
  • 5.3. Global Syringes Market Size & Trend Analysis, by Design, 2021 to 2033 (USD Million)
  • 5.4. Conventional Syringes
    • 5.4.1. Conventional syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Safety Syringes
    • 5.5.1. Safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.1. Retractable Safety Syringes
        • 5.5.1.1.1. Retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.2. Non-retractable Safety Syringes
        • 5.5.1.2.1. Non-retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Prefilled Syringes (PFS)
    • 5.6.1. Prefilled syringes (PFS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Smart Syringes
    • 5.7.1. Smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Syringes Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Syringes Market Application Movement Analysis
  • 6.3. Global Syringes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Vaccines and Immunizations
    • 6.4.1. Vaccines and immunizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Anaphylaxis
    • 6.5.1. Anaphylaxis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Rheumatoid Arthritis
    • 6.6.1. Rheumatoid arthritis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Diabetes
    • 6.7.1. Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Oncology
    • 6.9.1. Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Syringes Market: Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Syringes Market Material Movement Analysis
  • 7.3. Global Syringes Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 7.4. Plastic Syringes
    • 7.4.1. Plastic syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Glass Syringes
    • 7.5.1. Glass syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Syringes Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Syringes Market End Use Movement Analysis
  • 8.3. Global Syringes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Direct Tenders
    • 8.4.1. Direct tenders market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Hospital Pharmacies
    • 8.5.1. Hospital pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Retail Pharmacies
    • 8.6.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Online Pharmacies
    • 8.7.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Syringes Market: Regional Estimates & Trend Analysis By Design, By Usage, By Application, By Material, By End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Competitive scenario
      • 9.4.1.3. Regulatory framework
      • 9.4.1.4. Reimbursement scenario
      • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Competitive scenario
      • 9.5.1.3. Regulatory framework
      • 9.5.1.4. Reimbursement scenario
      • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. India
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Competitive scenario
      • 9.6.1.3. Regulatory framework
      • 9.6.1.4. Reimbursement scenario
      • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Competitive scenario
      • 9.7.1.3. Regulatory framework
      • 9.7.1.4. Reimbursement scenario
      • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
    • 10.2.1. Innovators
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Global Key company market share analysis, 2024
    • 10.3.4. Revital
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Design benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Hindustan Syringes & Medical Devices Ltd
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Design benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Wuxi Yushou Medical Appliances Co., Ltd
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Design benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Nipro Europe Group Companies
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Design benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Abu Dhabi Medical Devices Company
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Design benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. B. Braun SE
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Design benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. BD
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Design benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Sharps Technology, Inc.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Design benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Cardinal Health
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Design benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Vita Needle Company
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Design benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Terumo Europe NV
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Design benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Taisei Kako Ltd
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Design benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. ulti med Products
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Design benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Henke Sass Wolf GmbH
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Design benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. ITO CORPORATION
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Design benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Retractable Technologies, Inc.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Design benchmarking
      • 10.3.19.4. Strategic initiatives
    • 10.3.20. kohope.com
      • 10.3.20.1. Company overview
      • 10.3.20.2. Financial performance
      • 10.3.20.3. Design benchmarking
      • 10.3.20.4. Strategic initiatives
    • 10.3.21. Al Shifa Medical Products Co
      • 10.3.21.1. Company overview
      • 10.3.21.2. Financial performance
      • 10.3.21.3. Design benchmarking
      • 10.3.21.4. Strategic initiatives
    • 10.3.22. Liaoning Kangyi Medical Equipment Co., Ltd
      • 10.3.22.1. Company overview
      • 10.3.22.2. Financial performance
      • 10.3.22.3. Design benchmarking
      • 10.3.22.4. Strategic initiatives
    • 10.3.23. CANE SPA
      • 10.3.23.1. Company overview
      • 10.3.23.2. Financial performance
      • 10.3.23.3. Design benchmarking
      • 10.3.23.4. Strategic initiatives
    • 10.3.24. SMB Corporation of India
      • 10.3.24.1. Company overview
      • 10.3.24.2. Financial performance
      • 10.3.24.3. Design benchmarking
      • 10.3.24.4. Strategic initiatives
    • 10.3.25. Lifelong Meditech Private Limited.
      • 10.3.25.1. Company overview
      • 10.3.25.2. Financial performance
      • 10.3.25.3. Design benchmarking
      • 10.3.25.4. Strategic initiatives
    • 10.3.26. OSAKA CHEMICAL Co., Ltd
      • 10.3.26.1. Company overview
      • 10.3.26.2. Financial performance
      • 10.3.26.3. Design benchmarking
      • 10.3.26.4. Strategic initiatives
    • 10.3.27. JMS Co.Ltd
      • 10.3.27.1. Company overview
      • 10.3.27.2. Financial performance
      • 10.3.27.3. Design benchmarking
      • 10.3.27.4. Strategic initiatives
    • 10.3.28. APEX MEDICAL DEVICES
      • 10.3.28.1. Company overview
      • 10.3.28.2. Financial performance
      • 10.3.28.3. Design benchmarking
      • 10.3.28.4. Strategic initiatives
    • 10.3.29. Cartel Health Care Pvt. Ltd
      • 10.3.29.1. Company overview
      • 10.3.29.2. Financial performance
      • 10.3.29.3. Design benchmarking
      • 10.3.29.4. Strategic initiatives
    • 10.3.30. VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.)
      • 10.3.30.1. Company overview
      • 10.3.30.2. Financial performance
      • 10.3.30.3. Design benchmarking
      • 10.3.30.4. Strategic initiatives
    • 10.3.31. Fresenius Kabi Canada Ltd
      • 10.3.31.1. Company overview
      • 10.3.31.2. Financial performance
      • 10.3.31.3. Design benchmarking
      • 10.3.31.4. Strategic initiatives
    • 10.3.32. ICU Medical, Inc.
      • 10.3.32.1. Company overview
      • 10.3.32.2. Financial performance
      • 10.3.32.3. Design benchmarking
      • 10.3.32.4. Strategic initiatives
  • 10.4. Heat Map Analysis/ Company Market Position Analysis
  • 10.5. Estimated Company Market Share Analysis, 2024
  • 10.6. List of Other Key Market Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America syringes market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America syringes market, by design, 2021 - 2033 (USD Million)
  • Table 5. North America syringes market, by material, 2021 - 2033 (USD Million)
  • Table 6. North America syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 7. North America syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 8. North America syringes market, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. syringes market, by design, 2021 - 2033 (USD Million)
  • Table 10. U.S. syringes market, by material, 2021 - 2033 (USD Million)
  • Table 11. U.S. syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 12. U.S. syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 13. U.S. syringes market, by application, 2021 - 2033 (USD Million)
  • Table 14. Canada syringes market, by design, 2021 - 2033 (USD Million)
  • Table 15. Canada syringes market, by material, 2021 - 2033 (USD Million)
  • Table 16. Canada syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 17. Canada syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 18. Canada syringes market, by application, 2021 - 2033 (USD Million)
  • Table 19. Mexico syringes market, by design, 2021 - 2033 (USD Million)
  • Table 20. Mexico syringes market, by material, 2021 - 2033 (USD Million)
  • Table 21. Mexico syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 22. Mexico syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Mexico syringes market, by application, 2021 - 2033 (USD Million)
  • Table 24. Europe syringes market, by country, 2021 - 2033 (USD Million)
  • Table 25. Europe syringes market, by material, 2021 - 2033 (USD Million)
  • Table 26. Europe syringes market, by design, 2021 - 2033 (USD Million)
  • Table 27. Europe syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 28. Europe syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Europe syringes market, by application, 2021 - 2033 (USD Million)
  • Table 30. UK syringes market, by design, 2021 - 2033 (USD Million)
  • Table 31. UK syringes market, by material, 2021 - 2033 (USD Million)
  • Table 32. UK syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 33. UK syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 34. UK syringes market, by application, 2021 - 2033 (USD Million)
  • Table 35. Germany syringes market, by design, 2021 - 2033 (USD Million)
  • Table 36. Germany syringes market, by material, 2021 - 2033 (USD Million)
  • Table 37. Germany syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 38. Germany syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 39. Germany syringes market, by application, 2021 - 2033 (USD Million)
  • Table 40. France syringes market, by design, 2021 - 2033 (USD Million)
  • Table 41. France syringes market, by material, 2021 - 2033 (USD Million)
  • Table 42. France syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 43. France syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 44. France syringes market, by application, 2021 - 2033 (USD Million)
  • Table 45. Italy syringes market, by design, 2021 - 2033 (USD Million)
  • Table 46. Italy syringes market, by material, 2021 - 2033 (USD Million)
  • Table 47. Italy syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 48. Italy syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Italy syringes market, by application, 2021 - 2033 (USD Million)
  • Table 50. Spain syringes market, by design, 2021 - 2033 (USD Million)
  • Table 51. Spain syringes market, by material, 2021 - 2033 (USD Million)
  • Table 52. Spain syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 53. Spain syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Spain syringes market, by application, 2021 - 2033 (USD Million)
  • Table 55. Denmark syringes market, by design, 2021 - 2033 (USD Million)
  • Table 56. Denmark syringes market, by material, 2021 - 2033 (USD Million)
  • Table 57. Denmark syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 58. Denmark syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Denmark syringes market, by application, 2021 - 2033 (USD Million)
  • Table 60. Sweden syringes market, by design, 2021 - 2033 (USD Million)
  • Table 61. Sweden syringes market, by material, 2021 - 2033 (USD Million)
  • Table 62. Sweden syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 63. Sweden syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 64. Sweden syringes market, by application, 2021 - 2033 (USD Million)
  • Table 65. Norway syringes market, by design, 2021 - 2033 (USD Million)
  • Table 66. Norway syringes market, by material, 2021 - 2033 (USD Million)
  • Table 67. Norway syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 68. Norway syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 69. Norway syringes market, by application, 2021 - 2033 (USD Million)
  • Table 70. Asia Pacific syringes market, by country, 2021 - 2033 (USD Million)
  • Table 71. Asia Pacific syringes market, by material, 2021 - 2033 (USD Million)
  • Table 72. Asia Pacific syringes market, by design, 2021 - 2033 (USD Million)
  • Table 73. Asia Pacific syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 74. Asia Pacific syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Asia Pacific syringes market, by application, 2021 - 2033 (USD Million)
  • Table 76. China syringes market, by design, 2021 - 2033 (USD Million)
  • Table 77. China syringes market, by material, 2021 - 2033 (USD Million)
  • Table 78. China syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 79. China syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 80. China syringes market, by application, 2021 - 2033 (USD Million)
  • Table 81. Japan syringes market, by design, 2021 - 2033 (USD Million)
  • Table 82. Japan syringes market, by material, 2021 - 2033 (USD Million)
  • Table 83. Japan syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 84. Japan syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Japan syringes market, by application, 2021 - 2033 (USD Million)
  • Table 86. India syringes market, by design, 2021 - 2033 (USD Million)
  • Table 87. India syringes market, by material, 2021 - 2033 (USD Million)
  • Table 88. India syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 89. India syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 90. India syringes market, by application, 2021 - 2033 (USD Million)
  • Table 91. South Korea syringes market, by design, 2021 - 2033 (USD Million)
  • Table 92. South Korea syringes market, by material, 2021 - 2033 (USD Million)
  • Table 93. South Korea syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 94. South Korea syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 95. South Korea syringes market, by application, 2021 - 2033 (USD Million)
  • Table 96. Australia syringes market, by design, 2021 - 2033 (USD Million)
  • Table 97. Australia syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 98. Australia syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 99. Australia syringes market, by application, 2021 - 2033 (USD Million)
  • Table 100. Thailand syringes market, by design, 2021 - 2033 (USD Million)
  • Table 101. Thailand syringes market, by material, 2021 - 2033 (USD Million)
  • Table 102. Thailand syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 103. Thailand syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 104. Thailand syringes market, by application, 2021 - 2033 (USD Million)
  • Table 105. Latin America syringes market, by country, 2021 - 2033 (USD Million)
  • Table 106. Latin America syringes market, by material, 2021 - 2033 (USD Million)
  • Table 107. Latin America syringes market, by design, 2021 - 2033 (USD Million)
  • Table 108. Latin America syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 109. Latin America syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 110. Latin America syringes market, by application, 2021 - 2033 (USD Million)
  • Table 111. Brazil syringes market, by design, 2021 - 2033 (USD Million)
  • Table 112. Brazil syringes market, by material, 2021 - 2033 (USD Million)
  • Table 113. Brazil syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 114. Brazil syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 115. Brazil syringes market, by application, 2021 - 2033 (USD Million)
  • Table 116. Argentina syringes market, by design, 2021 - 2033 (USD Million)
  • Table 117. Argentina syringes market, by material, 2021 - 2033 (USD Million)
  • Table 118. Argentina syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 119. Argentina syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 120. Argentina syringes market, by application, 2021 - 2033 (USD Million)
  • Table 121. Middle East & Africa syringes market, by country, 2021 - 2033 (USD Million)
  • Table 122. Middle East & Africa syringes market, by material, 2021 - 2033 (USD Million)
  • Table 123. Middle East & Africa syringes market, by design, 2021 - 2033 (USD Million)
  • Table 124. Middle East & Africa syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 125. Middle East & Africa syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 126. Middle East & Africa syringes market, by application, 2021 - 2033 (USD Million)
  • Table 127. South Africa syringes market, by design, 2021 - 2033 (USD Million)
  • Table 128. South Africa syringes market, by material, 2021 - 2033 (USD Million)
  • Table 129. South Africa syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 130. South Africa syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 131. South Africa syringes market, by application, 2021 - 2033 (USD Million)
  • Table 132. Saudi Arabia syringes market, by design, 2021 - 2033 (USD Million)
  • Table 133. Saudi Arabia syringes market, by material, 2021 - 2033 (USD Million)
  • Table 134. Saudi Arabia syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 135. Saudi Arabia syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 136. Saudi Arabia syringes market, by application, 2021 - 2033 (USD Million)
  • Table 137. UAE syringes market, by design, 2021 - 2033 (USD Million)
  • Table 138. UAE syringes market, by material, 2021 - 2033 (USD Million)
  • Table 139. UAE syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 140. UAE syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 141. UAE syringes market, by application, 2021 - 2033 (USD Million)
  • Table 142. Kuwait syringes market, by design, 2021 - 2033 (USD Million)
  • Table 143. Kuwait syringes market, by material, 2021 - 2033 (USD Million)
  • Table 144. Kuwait syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 145. Kuwait syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 146. Kuwait syringes market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Syringes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Syringes Market, for Usage, 2021 - 2033 (USD Million)
  • Fig. 15 Syringes Market, for Disposable Syringes, 2021 - 2033 (USD Million)
  • Fig. 16 Syringes Market, for Reusable Syringes, 2021 - 2033 (USD Million)
  • Fig. 17 Syringes Market, for Design, 2021 - 2033 (USD Million)
  • Fig. 18 Syringes Market, for Conventional Syringes, 2021 - 2033 (USD Million)
  • Fig. 19 Syringes Market, for Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 20 Syringes Market, for Retractable Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 21 Syringes Market, for Non-Retractable Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 22 Syringes Market, for Prefilled Syringes (PFS), 2021 - 2033 (USD Million)
  • Fig. 23 Syringes Market, for Smart Syringes, 2021 - 2033 (USD Million)
  • Fig. 24 Syringes Market, for Material, 2021 - 2033 (USD Million)
  • Fig. 25 Syringes Market, for Plastic Syringes, 2021 - 2033 (USD Million)
  • Fig. 26 Syringes Market, for Glass Syringes, 2021 - 2033 (USD Million)
  • Fig. 27 Syringes Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 28 Syringes Market, for Vaccines and Immunizations, 2021 - 2033 (USD Million)
  • Fig. 29 Syringes Market, for Anaphylaxis, 2021 - 2033 (USD Million)
  • Fig. 30 Syringes Market, for Rheumatoid Arthritis, 2021 - 2033 (USD Million)
  • Fig. 31 Syringes Market, for Diabetes, 2021 - 2033 (USD Million)
  • Fig. 32 Syringes Market, for Autoimmune Diseases, 2021 - 2033 (USD Million)
  • Fig. 33 Syringes Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 34 Syringes Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 35 Syringes Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 36 Syringes Market, for Direct Tenders, 2021 - 2033 (USD Million)
  • Fig. 37 Syringes Market, for Hospital Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 38 Syringes Market, for Retail Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 39 Syringes Market, for Online Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Outlook, 2024 & 2033
  • Fig. 41 North America Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 44 Mexico Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 47 UK Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 48 France Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 49 Italy Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 50 Spain Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 52 Sweden Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 53 Norway Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 55 Japan Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 56 China Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 57 India Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 58 Australia Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 59 South Korea Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 60 Thailand Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East and Africa Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait Syringes Market, 2021 - 2033 (USD Million)